Molecular Imaging: Page 44

FDG-PET/CT has limits in esophageal cancer follow-up

By Wayne Forrest

FDG-PET/CT might be considered a double-edged sword when it comes to esophageal cancer. The modality fell short of identifying some higher tumor regression grades, but it detected interval metastases during post-treatment surveillance in a study published in the November issue of the Journal of Nuclear Medicine.

November 6, 2019

PET/MRI illuminates cerebral vascular risk factors

By Wayne Forrest

PET/MRI scans show middle-aged adults with high vascular risk factors have less whole-brain volume by the time they reach their late 60s, but their lifestyle and physical characteristics do not influence beta-amyloid accumulation, according to a study published online on 4 November in JAMA Neurology.

November 5, 2019

IMV: Global radiologists stay positive despite challenges

By Lorna Young

Radiologists in global markets are optimistic about future growth prospects for medical imaging procedures, but their priorities for imaging equipment are being dictated by local conditions. That's according to a new market research report by IMV Medical Information Division.

November 3, 2019

German team casts doubt on PET's value in Alzheimer's

By Wayne Forrest

Researchers from a leading German facility have investigated whether a person's progression from mild cognitive impairment to Alzheimer's disease can be reliably predicted without PET imaging. Their study published online on 18 October in the Journal of Nuclear Medicine lists several nonimaging methods that can offer a better prognosis than the modality.

October 30, 2019

RCR finds radioisotope import plan 'reassuring'

By AuntMinnieEurope.com staff writers

The U.K. Royal College of Radiologists (RCR) said the Department of Health and Social Care has confirmed that as of 21 October, all imported radioisotopes destined for U.K. hospitals should be entering the U.K. by air.

October 29, 2019

MR Solutions shows new PET/CT units at EANM 2019

By AuntMinnieEurope.com staff writers

Preclinical imaging technology developer MR Solutions showcased a line of preclinical PET/CT systems at the recent European Association of Nuclear Medicine (EANM) annual meeting in Barcelona, Spain.

October 22, 2019

GE, Theragnostics partner on PSMA agent

By AuntMinnieEurope.com staff writers

GE Healthcare and Theragnostics have signed a global partnership to develop a new prostate-specific membrane antigen (PSMA) PET/CT imaging agent.

October 8, 2019

Ga-68 PSMA PET/CT corrects therapy, saves money

By Wayne Forrest

Having recurrent prostate cancer patients undergo gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT can help direct clinicians to effectual curative treatment options that also are cost effective, according to a study by German researchers published in the October issue of the Journal of Nuclear Medicine.

October 8, 2019

Theragnostics promotes prostate cancer study

By AuntMinnieEurope.com staff writers

Radiopharmaceuticals firm Theragnostics is reporting encouraging results from a phase II clinical study on the efficacy of diagnostic imaging with gallium-68 (Ga-68) tris(hydroxypyridinone) prostate-specific membrane antigen (THP-PSMA) PET/CT for prostate cancer.

October 1, 2019

Quality control tests for PET/MRI vary widely in Europe

By Wayne Forrest

A survey of eight large European imaging facilities with extensive clinical experience of PET/MRI has found wide variations in daily quality control and assurance procedures that ensure their proper function and image quality. The international study was published on 24 September in Frontiers in Physics.

September 29, 2019

GE and partners to develop PET tracers

By AuntMinnieEurope.com staff writers

GE Healthcare is teaming up with three companies and one U.S. academic institution to develop a portfolio of PET tracers designed to better predict and monitor patient response to immunotherapies.

September 24, 2019

Affibody, GE to collaborate on PET tracers

By AuntMinnieEurope.com staff writers

Biopharmaceutical company Affibody and GE Healthcare are collaborating to develop and bring to market Affibody's PET imaging tracers.

September 19, 2019

Previous Page

Page 44 of 121

Next Page